Citations (101)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Muzaffer Temur, Gülçin Serpim, Sabiha Tuzluoğlu, Fatma Nurgül Taşgöz, Elif Şahin & Emin Üstünyurt. (2020) Comparison of serum human pregnancy-specific beta-1-glycoprotein 1 levels in pregnant women with or without preeclampsia. Journal of Obstetrics and Gynaecology 40:8, pages 1074-1078.
Read now
Read now
Stella Capriglione, Francesco Plotti, Corrado Terranova, Ferdinando Antonio Gulino, Federica Di Guardo, Salvatore Lopez, Giuseppe Scaletta & Roberto Angioli. (2020) Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature. The Journal of Maternal-Fetal & Neonatal Medicine 33:4, pages 677-686.
Read now
Read now
Nikolina Docheva, Roberto Romero, Piya Chaemsaithong, Adi L. Tarca, Gaurav Bhatti, Percy Pacora, Bogdan Panaitescu, Noppadol Chaiyasit, Tinnakorn Chaiworapongsa, Eli Maymon, Sonia S. Hassan & Offer Erez. (2019) The profiles of soluble adhesion molecules in the “great obstetrical syndromes”*. The Journal of Maternal-Fetal & Neonatal Medicine 32:13, pages 2113-2136.
Read now
Read now
Martina Montagnana, Elisa Danese, Giuseppe Lippi & Cristiano Fava. (2017) Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks?. Annals of Medicine 49:3, pages 240-253.
Read now
Read now
S. Masoura, I. A. Kalogiannidis, G. Gitas, A. Goutsioulis, E. Koiou, A. Athanasiadis & N. Vavatsi. (2012) Biomarkers in pre-eclampsia: A novel approach to early detection of the disease. Journal of Obstetrics and Gynaecology 32:7, pages 609-616.
Read now
Read now
Ulrich Pecks, Antje Schütt, Claudia Röwer, Toralf Reimer, Markus Schmidt, Stephanie Preschany, Holger Stepan, Werner Rath & Michael O. Glocker. (2012) A Mass Spectrometric Multicenter Study Supports Classification of Preeclampsia as Heterogeneous Disorder. Hypertension in Pregnancy 31:2, pages 278-291.
Read now
Read now
Sharon M. Cooley, Jennifer C. Donnelly, Michael P. Geary, Charles H. Rodeck & Peter C. Hindmarsh. (2010) Maternal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGF BP-3 and the hypertensive disorders of pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine 23:7, pages 658-661.
Read now
Read now
MaureenR. Gwinn & Ainsley Weston. (2008) Application of Oligonucleotide Microarray Technology to Toxic Occupational Exposures. Journal of Toxicology and Environmental Health, Part A 71:5, pages 315-324.
Read now
Read now
Krissada Paiwattananupant & Vorapong Phupong. (2008) Serum Inhibin A Level in Preeclampsia and Normotensive Pregnancy. Hypertension in Pregnancy 27:4, pages 337-343.
Read now
Read now
CKH Yu, L Lakasing, AT Papageorghiou, K Spencer & KH Nicolaides. (2004) Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 16:2, pages 134-139.
Read now
Read now
Ayse Gurbuz, Ates Karateke, Murat Mengulluoglu, Ali Gedikbasi, Mehmet Ozturkmen, Canan Kabaca & Zeki Sahinoglu. (2004) Can Serum HCG Values Be Used in the Differential Diagnosis of Pregnancy Complicated by Hypertension?. Hypertension in Pregnancy 23:1, pages 1-12.
Read now
Read now
Nick A. Bersinger & Rønnaug A. Ødegård. (2004) Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstetricia et Gynecologica Scandinavica 83:1, pages 37-45.
Read now
Read now
Articles from other publishers (89)
Sakita Moungmaithong, Angel H. Kwan, Ada W. Tse, Natalie K. Wong, Michelle S. Lam, Jing Wang, Liona C. Poon & Daljit S. Sahota. (2023) Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening. PLOS ONE 18:7, pages e0288289.
Crossref
Crossref
Jianye Deng, Hong-Jin Zhao, Ying Zhong, Cuiping Hu, Jinlai Meng, Chunling Wang, Xiangxin Lan, Xiyao Wang, Zi-Jiang Chen, Junhao Yan, Wei Wang & Yan Li. (2023) H3K27me3-modulated Hofbauer cell BMP2 signalling enhancement compensates for shallow trophoblast invasion in preeclampsia. eBioMedicine 93, pages 104664.
Crossref
Crossref
Courtney V. Barber, Jennifer H. Yo, Rahana Abdul Rahman, Euan M. Wallace, Kirsten R. Palmer & Sarah A. Marshall. (2023) Activin A and pathologies of pregnancy: a review. Placenta 136, pages 35-41.
Crossref
Crossref
Regina Komsa-Penkova, Sashka Krumova, Ariana Langari, Ina Giosheva, Lidia Gartcheva, Avgustina Danailova, Lora Topalova, Tanya Stoyanova, Velichka Strijkova, Alexey Savov & Svetla Todinova. (2023) Blood Plasma Calorimetric Profiles of Women with Preeclampsia: Effect of Oxidative Stress. Antioxidants 12:5, pages 1032.
Crossref
Crossref
Pooja Ramesh & Sudha Sumathy. (2023) Is Maternal Serum Homocysteine a Novel Diagnostic Biomarker for Predicting Placenta-Mediated Disorders?. Cureus.
Crossref
Crossref
Pooja Ramesh, S. Sudha & Vivek Krishnan. (2021) Association of combined second trimester maternal serum Homocysteine and Uterine Artery Doppler to predict adverse pregnancy outcome. The Journal of Obstetrics and Gynecology of India 72:4, pages 307-313.
Crossref
Crossref
Wilfried Gyselaers & Christoph Lees. (2022) Maternal Low Volume Circulation Relates to Normotensive and Preeclamptic Fetal Growth Restriction. Frontiers in Medicine 9.
Crossref
Crossref
Bhavisha A. Bakrania, Ana C. Palei, Umesh Bhattarai, Yingjie Chen, Joey P. Granger & Sajid Shahul. (2022) Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction. Cells 11:4, pages 742.
Crossref
Crossref
Yuyin Yi, Hua Zhu, Christian Klausen, Hsun-Ming Chang, Amy M. Inkster, Jefferson Terry & Peter C. K. Leung. (2021) Dysregulated BMP2 in the Placenta May Contribute to Early-Onset Preeclampsia by Regulating Human Trophoblast Expression of Extracellular Matrix and Adhesion Molecules. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Girija Naidoo, Olive P Khaliq, Jagidesa Moodley & Thajasvarie Naicker. (2021) The role of soluble E-selectin in HIV associated preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 257, pages 64-69.
Crossref
Crossref
Şule YILDIZ, Ümit Yasemin SERT, Esra BİLİR, Engin TÜRKGELDİ & Tuncay NAS. (2020) Prediction of Adverse Obstetric Outcomes by First Trimester Screening with Free β-hCG and PAPP-A: A Prospective Study of 889 Singleton PregnanciesBirinci Trimester Taramasında Bakılan Serum Belirteçlerinden β-hCG ve PAPP-A’nın Kötü Obstetrik Sonuçları Öngörmede Etkisi: 889 Tekil Gebelik ile yapılan Prospektif Bir Çalışma. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 17:4, pages 497-503.
Crossref
Crossref
Rafaianne Q. Moraes-Souza, Yuri K. Sinzato, Beatriz T. Antunes, Eduardo H. L. Umeoka, José Antônio C. Oliveira, Norberto Garcia-Cairasco, Barshana Karki, Gustavo T. Volpato & Débora Cristina Damasceno. (2020) Evaluation of Maternal Reproductive Outcomes and Biochemical Analysis from Wistar Audiogenic Rats (WAR) and Repercussions in Their Offspring. Reproductive Sciences 27:12, pages 2223-2231.
Crossref
Crossref
Wilfried Gyselaers. (2020) Preeclampsia Is a Syndrome with a Cascade of Pathophysiologic Events. Journal of Clinical Medicine 9:7, pages 2245.
Crossref
Crossref
Lisa Levine, Andreas Habertheuer, Chirag Ram, Laxminarayana Korutla, Nadav Schwartz, Robert W. Hu, Sanjana Reddy, Andrew Freas, Patrick D. Zielinski, Joey Harmon, Sudheer Kumar Molugu, Samuel Parry & Prashanth Vallabhajosyula. (2020) Syncytiotrophoblast extracellular microvesicle profiles in maternal circulation for noninvasive diagnosis of preeclampsia. Scientific Reports 10:1.
Crossref
Crossref
Susana M. Chuva de Sousa Lopes, Marta S. Alexdottir & Gudrun Valdimarsdottir. (2020) The TGFβ Family in Human Placental Development at the Fetal-Maternal Interface. Biomolecules 10:3, pages 453.
Crossref
Crossref
Enoch Appiah Adu-Gyamfi, Jones Lamptey, Fumei Duan, Ying-Xiong Wang & Yu-Bin Ding. (2019) The transforming growth factor β superfamily as possible biomarkers of preeclampsia: a comprehensive review. Biomarkers in Medicine 13:15, pages 1321-1330.
Crossref
Crossref
Zhengzheng Zhang, Hao Xu, Xiao Liu, Pan Li, Wensheng Du & Qiuyu Han. (2019) Association of pregnancy‑associated plasma protein A and vascular endothelial growth factor with pregnancy‑induced hypertension. Experimental and Therapeutic Medicine.
Crossref
Crossref
Sarah A. Marshall, Annie G. Cox, Laura J. Parry & Euan M. Wallace. (2019) Targeting the vascular dysfunction: Potential treatments for preeclampsia. Microcirculation 26:4, pages e12522.
Crossref
Crossref
Enrrico BloisePasquapina CiarmelaCynthia Dela CruzStefano LuisiFelice PetragliaFernando M. Reis. (2019) Activin A in Mammalian Physiology. Physiological Reviews 99:1, pages 739-780.
Crossref
Crossref
Edward Antwi, Kerstin Klipstein-Grobusch, Joyce L. Browne, Peter C. Schielen, Kwadwo A. Koram, Irene A. Agyepong & Diederick E. Grobbee. (2018) Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women. Reproductive Health 15:1.
Crossref
Crossref
Genevieve Eastabrook, Tuba Aksoy, Samantha Bedell, Debbie Penava & Barbra de Vrijer. (2018) Preeclampsia biomarkers: An assessment of maternal cardiometabolic health. Pregnancy Hypertension 13, pages 204-213.
Crossref
Crossref
C L Depoix, F Haegeman, F Debiève & C Hubinont. (2018) Is 8% O2 more normoxic than 21% O2 for long-term in vitro cultures of human primary term cytotrophoblasts?. MHR: Basic science of reproductive medicine 24:4, pages 211-220.
Crossref
Crossref
C. Iacobaeus, T. Kahan, G. Jörneskog, K. Bremme, E. Andolf & M. Thorsell. (2018) Pregnancy-associated plasma protein-A is positively correlated with first-trimester skin microvascular reactivity. Ultrasound in Obstetrics & Gynecology 51:3, pages 361-367.
Crossref
Crossref
Hannah Kim & Sung Shin Shim. (2017) Biomarkers and genetic factors for early prediction of pre-eclampsia. Journal of Genetic Medicine 14:2, pages 49-55.
Crossref
Crossref
Leonel García Benavides, Diego Hernández Molina, Jessica L. Barajas Vega, Sylvia E. Totsuka Sutton, Fernando Grover Paéz, Francisco J. Hernández Mora, Ernesto J. Ramírez Lizardo, Sara Pascoe Gonzalez, David Cardona Müller & Ernesto G. Cardona Muñoz. 2017. Obstetrics. Obstetrics.
I. V Ignatko, Violetta S. Florova, A. C Kuznetsov & E. Yu Kuzina. (2017) THE ROLE OF BIOCHEMICAL MARKERS IN THE RISK STRATIFICATION FOR DEVELOPMENT OF PREECLAMPSIA: THE CLINICIAN’S VIEW. V.F.Snegirev Archives of Obstetrics and Gynecology 4:4, pages 181-186.
Crossref
Crossref
Qiong Luo & Xiujun Han. (2017) Second-trimester maternal serum markers in the prediction of preeclampsia. Journal of Perinatal Medicine 45:7, pages 809-816.
Crossref
Crossref
Seema Saraswathy, Kavita Sahai, Tribhuvan Pal Yadav, Devendra Arora, Suman Lata Mendiratta, Samar Husain Naqvi, Shilpie Biswas, Manu Krishnan & Kurian Mathew Abraham. (2016) Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 6:4, pages 306-312.
Crossref
Crossref
A. Wright, L. Guerra, M. Pellegrino, D. Wright & K. H. Nicolaides. (2016) Maternal serum PAPP-A and free β-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia. Ultrasound in Obstetrics & Gynecology 47:6, pages 762-767.
Crossref
Crossref
Samantha L. Wilson, John D. Blair, Kirsten Hogg, Sylvie Langlois, Peter von Dadelszen & Wendy P. Robinson. (2015) Placental DNA methylation at term reflects maternal serum levels of INHA and FN1, but not PAPPA, early in pregnancy. BMC Medical Genetics 16:1.
Crossref
Crossref
Hee Park, Sung Shim & Dong Cha. (2015) Combined Screening for Early Detection of Pre-Eclampsia. International Journal of Molecular Sciences 16:8, pages 17952-17974.
Crossref
Crossref
R. Lim, S. Adhikari, S. Gurusinghe, B. Leaw, R. Acharya, R. Rahman, R. Ciayadi, M. Potdar, G.F. Kelso, M.T.W. Hearn & E.M. Wallace. (2015) Inhibition of activin A signalling in a mouse model of pre-eclampsia. Placenta 36:8, pages 926-931.
Crossref
Crossref
D. Wright, M. Silva, S. Papadopoulos, A. Wright & K. H. Nicolaides. (2015) Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound in Obstetrics & Gynecology 46:1, pages 42-50.
Crossref
Crossref
Rachel D. Williamson, Gerard W. O’Keeffe & Louise C. Kenny. (2015) Activin signalling and pre-eclampsia: From genetic risk to pre-symptomatic biomarker. Cytokine 71:2, pages 360-365.
Crossref
Crossref
Lili Zhao, Jonathan Blackburn & Christa L. Brosseau. (2014) Quantitative Detection of Uric Acid by Electrochemical-Surface Enhanced Raman Spectroscopy Using a Multilayered Au/Ag Substrate. Analytical Chemistry 87:1, pages 441-447.
Crossref
Crossref
Qinglei Li. (2014) Transforming growth factor β signaling in uterine development and function. Journal of Animal Science and Biotechnology 5:1.
Crossref
Crossref
Yogeshwar MakanjiJie ZhuRama MishraChris HolmquistWinifred P. S. WongNeena B. Schwartz, Kelly E. Mayo & Teresa K. Woodruff. (2014) Inhibin at 90: From Discovery to Clinical Application, a Historical Review. Endocrine Reviews 35:5, pages 747-794.
Crossref
Crossref
K. Hogg, W.P. Robinson & A.G. Beristain. (2014) Activation of endocrine-related gene expression in placental choriocarcinoma cell lines following DNA methylation knock-down. MHR: Basic science of reproductive medicine 20:7, pages 677-689.
Crossref
Crossref
Leona C. Poon & Kypros H. Nicolaides. (2014) First-trimester maternal factors and biomarker screening for preeclampsia. Prenatal Diagnosis 34:7, pages 618-627.
Crossref
Crossref
Michael O. Glocker, Claudia Röwer, Manja Wölter, Cornelia Koy, Toralf Reimer & Ulrich Pecks. 2014. Handbook of Spectroscopy. Handbook of Spectroscopy
407
428
.
Leona C. Poon & Kypros H. Nicolaides. (2014) Early Prediction of Preeclampsia. Obstetrics and Gynecology International 2014, pages 1-11.
Crossref
Crossref
Seshini Gurusinghe, Euan M. Wallace & Rebecca Lim. (2014) The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 4:1, pages 3-6.
Crossref
Crossref
Jonathan Lai, Ana Pinas, Leona C.Y. Poon, Maria Agathokleous & Kypros H. Nicolaides. (2013) Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free β-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia. Fetal Diagnosis and Therapy 33:3, pages 164-172.
Crossref
Crossref
Sue Hyun Oh & Heung Yeol Kim. (2012) Predictive Value of Maternal Serum Markers for Preeclampsia. Kosin Medical Journal 27:2, pages 91-97.
Crossref
Crossref
S Sifakis, R Akolekar, D Kappou, N Mantas & K H Nicolaides. (2011) Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11–13 weeks in preeclampsia. Journal of Human Hypertension 26:4, pages 253-258.
Crossref
Crossref
Dongxiao Hu, Ting Tian, Jing Guo, Hanzhi Wang, Danqing Chen & Minyue Dong. (2012) Decreased maternal and placental concentrations of follistatin-like 3 in gestational diabetes. Clinica Chimica Acta 413:5-6, pages 533-536.
Crossref
Crossref
Narges Moslemi Zadeh, Farshad Naghshvar, Sepideh Peyvandi, Parand Gheshlaghi & Sara Ehetshami. (2012) PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?. ISRN Obstetrics and Gynecology 2012, pages 1-6.
Crossref
Crossref
Yuxuan Chen & Zhenyu Zhang. (2012) Placenta related pathogenic factors for preeclampsia. Open Journal of Obstetrics and Gynecology 02:04, pages 340-345.
Crossref
Crossref
Alev Atis, Yavuz Aydin, Elif Basol, Semih Kaleli, Fatma Turgay & Nimet Goker. (2011) PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome. Archives of Gynecology and Obstetrics 285:1, pages 45-49.
Crossref
Crossref
Maria De Bonis, Michela Torricelli & Felice Petraglia. 2012. Neonatology. Neonatology
21
25
.
Pamela K Wagner, Aki Otomo & Julian K Christians. (2011) Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo). Reproductive Biology and Endocrinology 9:1.
Crossref
Crossref
Minoru Mitani, Yoshio Matsuda, Etsuko Shimada, Aiko Kobayashi, Yoshika Akizawa, Yayoi Kawamichi, Yasuo Makino & Hideo Matsui. (2011) Levels of soluble endothelial selectin in umbilical cord serum are influenced by gestational age and histological chorioamnionitis, but not by pre-eclampsia. Journal of Obstetrics and Gynaecology Research 37:12, pages 1818-1823.
Crossref
Crossref
Miho Kodama, Hiroshi Miyoshi, Naoya Fujito, Osamu Samura & Yoshiki Kudo. (2011) Plasma mRNA concentrations of placenta-specific 1 (PLAC1) and pregnancy associated plasma protein A (PAPP-A) are higher in early-onset than late-onset pre-eclampsia. Journal of Obstetrics and Gynaecology Research 37:4, pages 313-318.
Crossref
Crossref
Sylwia Kuc, Esther J. Wortelboer, Bas B. van Rijn, Arie Franx, Gerard H. A. Visser & Peter C. J. I. Schielen. (2011) Evaluation of 7 Serum Biomarkers and Uterine Artery Doppler Ultrasound for First-Trimester Prediction of Preeclampsia: A Systematic Review. Obstetrical & Gynecological Survey 66:4, pages 225-239.
Crossref
Crossref
Anne Cathrine Staff. (2011) Circulating predictive biomarkers in preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 1:1, pages 28-42.
Crossref
Crossref
Kelly L. Walton, Yogeshwar Makanji, David M. Robertson & Craig A. Harrison. 2011. Activins and Inhibins. Activins and Inhibins
149
184
.
Roger E. Kelley, Maike Tiede Blaya & Patricia Colon. 2011. Neurological Disorders and Pregnancy. Neurological Disorders and Pregnancy
79
90
.
Ulrich Pecks, Franka Seidenspinner, Claudia Röwer, Toralf Reimer, Werner Rath & Michael O. Glocker. (2010) Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: A strategy to distinguish patients with preeclampsia from matching control individuals. Journal of the American Society for Mass Spectrometry 21:10, pages 1699-1711.
Crossref
Crossref
Julian K. Christians & Andrée Gruslin. (2010) Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction. Prenatal Diagnosis 30:9, pages 815-820.
Crossref
Crossref
Anne Mette Hoegh, Rehannah Borup, Finn Cilius Nielsen, Steen Sørensen & Thomas V. F. Hviid. (2010) Gene Expression Profiling of Placentas Affected by Pre-Eclampsia. Journal of Biomedicine and Biotechnology 2010, pages 1-11.
Crossref
Crossref
RT Blankley, SJ Gaskell, AD Whetton, C Dive, PN Baker & JE Myers. (2009) A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology 116:11, pages 1473-1480.
Crossref
Crossref
Ranjit Akolekar, Ryoko Minekawa, Alina Veduta, Ximena C. Romero & Kypros H. Nicolaides. (2009) Maternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy. Prenatal Diagnosis 29:8, pages 753-760.
Crossref
Crossref
E.S. Hutchinson, P. Brownbill, N.W. Jones, V.M. Abrahams, P.N. Baker, C.P. Sibley & I.P. Crocker. (2009) Utero-Placental Haemodynamics in the Pathogenesis of Pre-Eclampsia. Placenta 30:7, pages 634-641.
Crossref
Crossref
Asma Khalil, Eric Jauniaux, Kevin Harrington & Shanthi Muttukrishna. (2009) Placental production and maternal serum and urine levels of inhibin A and activin A are modified by antihypertensive therapy in hypertensive disorders of pregnancy. Clinical Endocrinology 70:6, pages 924-931.
Crossref
Crossref
N.A. Bersinger & M.U. Baumann. (2009) Serum markers for pre-eclampsia: An update on the analytes to be determined in the first, second, and third trimester. Immuno-analyse & Biologie Spécialisée 24:2, pages 58-68.
Crossref
Crossref
Koksal Deveci, Erkan Sogut, Osman Evliyaoglu & Nuriye Duras. (2009) Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester. Journal of Obstetrics and Gynaecology Research 35:1, pages 94-98.
Crossref
Crossref
Linda T Roten, Matthew P Johnson, Siri Forsmo, Elizabeth Fitzpatrick, Thomas D Dyer, Shaun P Brennecke, John Blangero, Eric K Moses & Rigmor Austgulen. (2008) Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). European Journal of Human Genetics 17:2, pages 250-257.
Crossref
Crossref
K. Spencer, N. J. Cowans & K. H. Nicolaides. (2008) Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia. Ultrasound in Obstetrics and Gynecology 32:5, pages 622-626.
Crossref
Crossref
Jin Hee Kang, Antonio Farina, Ji Hyeon Park, Sung Han Kim, Ji Yeon Kim, Nicola Rizzo, Amira Elmakky, Hye Sun Jun, Won Bo Hahn & Dong Hyun Cha. (2008) Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenatal Diagnosis 28:8, pages 704-709.
Crossref
Crossref
David M. Carty, Christian Delles & Anna F. Dominiczak. (2008) Novel Biomarkers for Predicting Preeclampsia. Trends in Cardiovascular Medicine 18:5, pages 186-194.
Crossref
Crossref
Kevin Spencer, Nicholas J. Cowans & Anastasia Stamatopoulou. (2008) ADAM12s in maternal serum as a potential marker of pre‐eclampsia. Prenatal Diagnosis 28:3, pages 212-216.
Crossref
Crossref
K. Mine, A. Katayama, T. Matsumura, T. Nishino, Y. Kuwabara, G. Ishikawa, T. Murata, R. Sawa, Y. Otsubo, S. Shin & T. Takeshita. (2007) Proteome Analysis of Human Placentae: Pre-eclampsia Versus Normal Pregnancy. Placenta 28:7, pages 676-687.
Crossref
Crossref
N.A. Bersinger & R.A. Ødegård. (2007) Second-trimester serum levels of placenta growth factor (PLGF) and inhibin A are increased in smokers. Implications for pre-eclampsia risk assessment. Immuno-analyse & Biologie Spécialisée 22:1, pages 19-23.
Crossref
Crossref
Benjamin D. Hamar, Irina A. Buhimschi, Anna K. Sfakianaki, Christian M. Pettker, Lissa K. Magloire, Edmund F. Funai, Joshua A. Copel & Catalin S. Buhimschi. (2006) Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia. American Journal of Obstetrics and Gynecology 195:6, pages 1636-1645.
Crossref
Crossref
Antonio Farina, Akihiko Sekizawa, Yuditiya Purwosunu, Nicola Rizzo, Irina Banzola, Manuela Concu, Danila Morano, Federica Giommi, Maurizio Bevini, Mohamad Mabrook, Paolo Carinci & Takashi Okai. (2006) Quantitative distribution of a panel of circulating mRNA in preeclampsiaversus controls. Prenatal Diagnosis 26:12, pages 1115-1120.
Crossref
Crossref
Rebecca L Jones, Chelsea Stoikos, Jock K Findlay & Lois A Salamonsen. (2006) TGF-β superfamily expression and actions in the endometrium and placenta. Reproduction 132:2, pages 217-232.
Crossref
Crossref
Marcel Zwahlen, Susan Gerber & Nick A. Bersinger. (2006) First Trimester Markers for Pre-Eclampsia: Placental vs<i>.</i> Non-Placental Protein Serum Levels. Gynecologic and Obstetric Investigation 63:1, pages 15-21.
Crossref
Crossref
K. Spencer, C. K. H. Yu, M. Savvidou, A. T. Papageorghiou & K. H. Nicolaides. (2006) Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free β-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound in Obstetrics and Gynecology 27:6, pages 658-663.
Crossref
Crossref
Bruce B. Feinberg. (2006) Preeclampsia: the Death of Goliath. American Journal of Reproductive Immunology 55:2, pages 84-98.
Crossref
Crossref
V. Tsatsaris, A. Malassiné, T. Fournier, K. Handschuh, J.-P. Schaaps, J.-M. Foidart & D. Evain-Brion. (2006) Placenta humana. EMC - Ginecología-Obstetricia 42:2, pages 1-23.
Crossref
Crossref
V. Tsatsaris, A. Malassiné, T. Fournier, K. Handschuh, J.-P. Schaaps, J.-M. Foidart & D. Evain-Brion. (2006) Placenta humain. EMC - Obstétrique 1:1, pages 1-22.
Crossref
Crossref
Nick A. Bersinger & Alexander K. Smarason. (2005) Pre-eclampsia: increased, unchanged, and decreased serum markers in comparison to healthy third trimester pregnancy. A synopsis. Immuno-analyse & Biologie Spécialisée 20:6, pages 353-359.
Crossref
Crossref
Kevin Spencer, Christina K. H. Yu, Nicholas J. Cowans, Chineze Otigbah & Kypros H. Nicolaides. (2005) Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery Doppler. Prenatal Diagnosis 25:10, pages 949-953.
Crossref
Crossref
Donna M. Neale & Gil Mor. (2005) The role of Fas mediated apoptosis in preeclampsia. Journal of Perinatal Medicine 33:6.
Crossref
Crossref
David J. Phillips. (2005) Activins, inhibins and follistatins in the large domestic species. Domestic Animal Endocrinology 28:1, pages 1-16.
Crossref
Crossref
Berthold Huppertz & John C. P. Kingdom. (2016) Apoptosis in the Trophoblast—Role of Apoptosis in Placental Morphogenesis. Journal of the Society for Gynecologic Investigation 11:6, pages 353-362.
Crossref
Crossref
Nick A Bersinger & Rønnaug Ødegård. (2004) Early biochemical detection of pre-eclampsia: the role of placental proteins. Immuno-analyse & Biologie Spécialisée 19:1, pages 47-53.
Crossref
Crossref
Shin-Young KimHyun-Mee RyuJae Hyug YangMoon-Young KimHyun-Kyong AhnHa-Jung LimJoong-Sik ShinHyuk-Jun WooSo-Yeon ParkYoung-Mi KimJin-Woo KimEun Hee Cho. (2004) Maternal Serum Levels of VCAM-1, ICAM-1 and E-selectin in Preeclampsia. Journal of Korean Medical Science 19:5, pages 688.
Crossref
Crossref
Sunil K Nadar, Eman Al Yemeni, Andrew D Blann & Gregory Y.H Lip. (2004) Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension. Thrombosis Research 113:2, pages 123-128.
Crossref
Crossref